Baker Daniel G. 4
4 · Artiva Biotherapeutics, Inc. · Filed Jan 29, 2025
Insider Transaction Report
Form 4
Baker Daniel G.
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2025-01-28+27,500→ 27,500 totalExercise: $5.56Exp: 2035-01-27→ Common Stock (27,500 underlying)
Footnotes (1)
- [F1]One-third of the shares vested following the grant date, with the remaining shares vesting monthly over an additional two years following January 28, 2025,